Substituted hydroxy-heterocyclyl-alkoxy phosphinyloxy trialkylaminium hydroxide inner salt oxides, processes for their preparation and their use as pharmaceuticals
申请人:SANDOZ AG
公开号:EP0213082A1
公开(公告)日:1987-03-04
Compounds of formula I
wherein
R represents hydrogen, C 14-18 -alkyl or CHzOR2 CH2CH2OR2, wherein R2 represents C14-18alkyl
each R, represents independently C1-3 alkyl m is l or 2
n is an integer from 2 to 8
and R4 and R5 together with the adjacent carbon atom represent
wherein R3 represents alkyl, alkenyl, alkynyl, alkoxy, alkenoxy or alkynoxy each containing 12 to 24 carbon atoms
whereby when R4 and R5 together with the adjacent carbon represent (i) ring e) R is H and (ii) other than ring e) R is other than H
which exhibit pharmaceutical in particular anti-tumor activity.
化合物的分子式为I,
其中R代表氢,C14-18烷基或CH2OR2 CH2CH2OR2,其中R2代表C14-18烷基,每个R独立地代表C1-3烷基,m为1或2,n为2至8的整数,
R4和R5与相邻的碳原子结合,其中R3代表含有12至24个碳原子的烷基,烯基,炔基,烷氧基,烯氧基或炔氧基,
当R4和R5与相邻碳原子结合时,(i)环e)中R为H,(ii)除环e)外的其他环中R不为H,
这些化合物表现出药理学特别是抗肿瘤活性。